Updated: May 19, 2026

Nancy A Simonian

GENBGenerate Biomedicines, Inc.SEC CIK: 0001359574
Estimated Net Worth
$16.4 Million
Last Updated: May 19, 2026 11:18 PM EST

Transaction Summary

Total Transactions59
Buy-Sell Ratio0.00
Buy Transactions0
Sell Transactions6

Transaction Volume

Total Volume-$1.25M
Net Volume$1.25M
Buy Volume$0.00
Sell Volume-$1.25M

Trade Analysis

AVG Trade Size-$259.12K
Largest Trade$501.00K
Most Active MonthMay
Most Active Year2023

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Nancy A Simonian has an estimated net worth of $16.4 Million. This is based on reported shares across multiple companies, which include Seagen Inc., Syros Pharmaceuticals, Inc., Evelo Biosciences, Inc., ARQULE INC, MILLENNIUM PHARMACEUTICALS INC, and Generate Biomedicines, Inc..



2018 was Nancy A Simonian's most active year for acquiring shares with 9 total transactions. Nancy A Simonian's most active month to acquire stocks was the month of April. 2008 was Nancy A Simonian's most active year for disposing of shares, totalling 24 transactions. Nancy A Simonian's most active month to dispose stocks was the month of November. 2007 saw Nancy A Simonian paying a total of $895,355.42 for 120,834 shares, this is the most they've acquired in one year. In 2023 Nancy A Simonian cashed out on 302,110 shares for a total of $14,404,965.38, their largest year based on trade value.

Holdings & Transactions

GENBgenerate biomedicines, inc.
Updated: Mar 02, 2026VIEW QUOTE
Form TypeSEC Filing
29.56K29.56KFeb 26View
View
SYRSsyros pharmaceuticals, inc.
Updated: Dec 04, 2024VIEW QUOTE
Form TypeSEC Filing
-0.9037.07K$0.27-$10.02K4.00KDec 02View
-0.77134.71K$0.27-$35.74K41.07KNov 25View
175.78KOct 31View
0.0810.00K141.66KJun 05View
-0.0614.05K$5.12-$71.95K222.79KMar 31 - 01View
-1.00112.80KDec 01View
-0.0913.40K$2.22-$29.75K140.27KOct 31 - 01View
-0.021.85K$2.58-$4.78K91.42KMar 31 - 03View
118.70K118.70KFeb 16View
195.25K195.25KOct 06View
-0.0858.88K$1.12-$65.95K692.72KApr 01View
1.01M1.02MFeb 15View
304.00K304.00KFeb 17View
$6.81$203.61K944.31KDec 18View
294.00K294.00KFeb 13View
$3.04$159.30K2.59MDec 23View
0.98473.00K954.29KFeb 12View
0.11221.18K$1.23$136.22K2.06MNov 29View
285.00K285.00KFeb 16View
175.00K175.00KFeb 10View
75.00K75.00KSep 16View
-0.33183.33K530.70KJul 06View
464.04KView
SGENseagen inc.
Updated: Dec 15, 2023VIEW QUOTE
Form TypeSEC Filing
-1.00127.93K$229.00-$14.37MDec 14View
0.032.04K64.80KMay 31View
$36.70$321.13K62.75KDec 12View
0.105.18K57.68KMay 13View
$20.04$501.00K52.50KMar 02View
0.194.86K30.96KMay 14View
0.184.51K29.27KMay 15View
0.4610.00K31.80KMay 20View
0.7212.96K31.06KMay 18View
0.9012.96K27.36KMay 19View
1.2112.96K23.66KMay 20View
1.8512.96K19.96KMay 15View
3.5012.25K$34.25$299.69K15.75KMay 16View
12.25K$36.70$321.13K12.25KMay 17View
25.00K$20.04$501.00K25.00KMar 19View
View
EVLOevelo biosciences, inc.
Updated: Jun 18, 2020VIEW QUOTE
Form TypeSEC Filing
15.69K15.69KJun 17View
15.69K15.69KJun 12View
31.38K31.38KMay 08View
View
arqule inc
Updated: May 17, 2010
Form TypeSEC Filing
0.3015.00K65.00KMay 13View
0.2510.00K50.00KMay 14View
0.3310.00K40.00KMay 15View
0.5010.00K30.00KMay 18View
1.0010.00K20.00KMay 18View
10.00K10.00KMay 12View
View
millennium pharmaceuticals inc
Chief Medical Officer Officer
Updated: May 15, 2008
Form TypeSEC Filing
-1.00572.60K$25.00-$1.94MMay 14View
-0.032.13K$24.88-$53.07K82.39KScheduledMay 01View
-0.1917.54K$13.35-$234.17K80.21KScheduledMar 05 - 06View
-0.055.00K$13.87-$69.37K97.75KScheduledFeb 29 - 03View
2.55170.15K241.96KFeb 14View
-0.44113.06K$11.76-$850.41K151.26KDec 13View
73.44KView